Related Experiment Videos
[Benign prostatic hyperplasia--treatment with sabal fruit extract. A treatment study of 1,334 patients]
W Vahlensieck1, A Völp, W Lubos
1Urologische Klinik und Poliklinik, Klinikum Grosshadern der Universität München.
Method:
In a drug monitoring study, 1,334 outpatients with benign prostatic hyperplasia (BPH) were treated for 12 weeks with an extract from the fruits of Sabal serrulata.
Results:
Under this treatment, the volume of residual urine decreased by 50%, pollakisuria decreased on average by 37%, and nocturia by 54%. The percentage of patients with dysuric pain decreased from 75% to 37%. The efficacy of the drug was rated good to excellent in more than 80% of the cases, and good to excellent tolerability was reported by more than 95% of the patients.
Conclusion:
The improvement in the irritative symptoms may be considered relevant in terms of improvement in the quality of the life of the patients, and justifies this form of treatment.